Navigation Links
Nuvilex to Issue Positive Shareholder Newsletter
Date:8/25/2009

CHERRY HILL, N.J., Aug. 25 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), announces today that it will issue a shareholder newsletter on September 1, 2009. Additionally, regional shareholder meetings will be held in New York City on September 16th, Chicago on September 17th, and Los Angeles on September 18th. Regional shareholder meeting times and locations will be announced on or before September 7, 2009.

"We are very aware of our shareholders' interest in our business endeavors," stated Martin Schmieg, Chairman and Chief Executive Officer of Nuvilex, Inc. "Like all public companies, the accounting and legal requirements of what we can and must say in our annual and quarterly SEC filings often times paints a less than favorable picture of the positive progress the Company is making in product development, marketing and sales and improving its financial condition."

"Nuvilex is a Company with great promise and a strong future," continued Schmieg. Unlike most development and early revenue stage companies who typically have a single technology or product, Nuvilex has ten unique product opportunities in four diverse markets.

The current business challenge facing Nuvilex is successfully marketing the company's high quality, differentiated and competitively priced products. "We believe these products will become highly sought after, but this will only happen after consumers become aware that our products exist and can be easily obtained," said Schmieg. "This requires building brand awareness and distribution channels."

As a small company, Nuvilex, plans to market the Company's products effectively and efficiently without raising large sums of money (highly dilutive) through the following three-part business strategy:

  1. Focus on short-term successes that can maximize and drive immediate revenue growth and cash in-flows
    '/>"/>

SOURCE Nuvilex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Nuvilex Completes First Sale of Last Shot Hangover Remedy(TM)
2. Nuvilex, Inc. Announces Business Update Conference Call
3. Nuvilex Cites Study that Suggests Red Yeast Rice, an Active Ingredient in Cinnechol, Can Help to Improve Cardiovascular Health
4. Nuvilex Renews MedX Master Distribution Agreement and Implements New Pricing for Talsyn Scar Cream
5. Nuvilex Featured in Wall Street Reporter Interview
6. Nuvilex Offers Free Cinnergen Samples in Response to Spike in Consumer Interest
7. Nuvilex Launches Video Marketing Campaign
8. Nuvilex Gets Update from CK41 on purEffect(TM) Launch Plan
9. Nuvilex Signs Agreement with Jayhur Enterprises to Distribute Infinitink - the Worlds First Permanent, But Easier to Remove Tattoo Ink - in Australia and New Zealand
10. Time Magazine Reports on Infinitink Tattoo Ink From Nuvilex
11. Nuvilex, Inc. Announces Monthly Investor Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... New York (PRWEB) December 21, 2014 ... and other product liability claims involving a class ... mimetics continue to move forward in a federal ... Southern District of California, Bernstein Liebhard LLP reports. ... Court has established a data cut-off date of ...
(Date:12/21/2014)... San Francisco, California (PRWEB) December 21, 2014 ... announces his search for Vintage 1967 Jm Morrison and the ... D.C. concert posters. This would also be the only ... live. The concert was on Nov. 25, 1967. According ... in Washington D.C. They did play the Alexandria Roller ...
(Date:12/21/2014)... 2014 As testosterone therapy lawsuit ... stroke and blood clots from using testosterone products such ... study shows that the male hormone testosterone may increase ... study published in the Proceedings of the National Academy ... a group of male rats with naturally occurring colon ...
(Date:12/20/2014)... BambooIndustry.com is a leading eco-friendly ... announced its bamboo flooring promotion for the coming ... certified suppliers, and offers the best bamboo products ... current promotion, all customers can enjoy a special ... they know BambooIndustry.com from press releases. , The ...
(Date:12/20/2014)... December 20, 2014 DePuy Pinnacle ... metal-on-metal version of the artificial hip system was ... and federal courts, Bernstein Liebhard LLP reports. According ... County Superior Court on December 2nd, counsel in ... deposition of plaintiffs on November 19, 2014, with ...
Breaking Medicine News(10 mins):Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 2Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 3Health News:Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics Litigation, Bernstein Liebhard LLP Report 4Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 2Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 3Health News:New Low Testosterone Therapy Study Shows Male Hormone Testosterone May Contribute To Colon Cancer Reports Wright & Schulte LLC 4Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 2Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 3Health News:New Jersey Court Overseeing DePuy Pinnacle Hip Lawsuits Issues New Order, Bernstein Liebhard LLP Reports 4
... Administrative Services to begin operations in Seattle , ... Employee Benefits, a national carrier of life and disability ... a new Administrative Services department in Seattle, Wa. , ... acquisition of certain capabilities, technology assets, and employees of ...
... best way to avoid deep vein thrombosis, report says ... no proof that genetic testing can help prevent the ... new U.S. government report shows. , The presence of ... G20210A can signal continued risk of blood clots, according ...
... with, study finds , TUESDAY, June 16 (HealthDay News) --Being ... doesn,t mean you,re doomed to have it, a long-term study ... pressure is affected by genes," said Dr. Nora Franceschini, an ... and lead author of a report on the study. "It,s ...
... to Receive Up to $400,000 in Funding - Application ... June 16 The GlaxoSmithKline IMPACT Awards target community-based ... Up to ten organizations in Berks, Bucks, Chester, ... awarded $40,000 each. The awards are bestowed upon ...
... Uses "Pop Culture Moment" to Advocate for Safe RN Staffing Levels ... The three nursing organizations at the heart of the newly ... advertising campaign in conjunction with the debut of HawthoRNe, ... nurse characters. The ad can be viewed here: ...
... Technology announced the release of The Observer(R) XT 9.0, ... release, Noldus announced the launch of Pocket Observer 3.0. ... handheld computer, making on-site research easy. , ... in more than 2000 scientific publications, The Observer XT ...
Cached Medicine News:Health News:Assurant Employee Benefits Adds New Voluntary Capabilities 2Health News:No Benefit in Testing for Genes Linked to Leg Clots 2Health News:Lifestyle May Counter Blood Pressure Genes 2Health News:Lifestyle May Counter Blood Pressure Genes 3Health News:GlaxoSmithKline 13th Annual IMPACT Awards Seek Nonprofits Providing Access to Healthcare 2Health News:National Nurses Movement Launches Ad Campaign for Nurse TV Shows 2Health News:Noldus Announces The Observer XT 9.0 2
(Date:12/19/2014)... , Dec. 18, 2014   Aratana ... a biopharmaceutical company focused on the licensing, development ... today announced positive results from its pivotal field ... for treating pain in dogs with osteoarthritis.  In ... pain assessment scores that were statistically significant compared ...
(Date:12/17/2014)... 17, 2014 Los beneficios y ... alto nivel de gasto en investigación y desarrollo   ... el 30 de septiembre de 2014) ZEISS aumentó sus ... de euros (año anterior: 4.190 millones de euros) a ... ganancias (EBIT) crecieron un 14 por ciento, a 360 ...
(Date:12/17/2014)... , Dec. 17, 2014 With ... (MRI), the MRI market is seeing new growth, ... breast MRI scans account for the majority of ... higher resolution of images, which are creating opportunities for ... (MRI) market is growing at a rate of ...
Breaking Medicine Technology:Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 2Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 3Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 4Aratana Therapeutics Announces Positive Top-Line Results from AT-001 Pivotal Field Study in Client-Owned Dogs with Osteoarthritis 5ZEISS confirma su posición en un entorno difícil 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 2Kalorama: 3T Advancements Bringing New Growth to the MRI Market 3
... Nov. 16, 2011 Reportlinker.com announces that a ... catalogue: X-ray Equipment - Top ... This package contains top 5 ... China, Japan, India, South Koera, and Indonesia. ...
... Nov. 16, 2011 Reportlinker.com announces ... is available in its catalogue: ... Angiogenesis and Peptides ... triple analysis focuses on cancer drug ...
Cached Medicine Technology:X-ray Equipment - Top 5 Asian Markets 2Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 2Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 3Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 4Triple Analysis: Prostate Cancer, Angiogenesis and Peptides 5
The GC OIA test is a rapid assay for the diagnosis of gonorrhea. Thermo solved the challenge of developing a specific rapid assay for Neisseria gonorrhea by using the proprietary ribosomal protein, ...
... FLU OIA test is a high performance ... Influenza A and B with a simple, ... just over 15 minutes. Assay advantages include ... and performance equivalent to 14-day viral culture ...
... The CHLAYMDIA OIA test delivers 100% ... results in 19 minutes. With ... not returning for follow-up, this assay ... which can contribute to detection and ...
... Botox therapy and nerve block procedures, ... needle has a precisely machined Trocar ... an attached 61-cm (24-in) lead wire. ... Single patient use only. A starter ...
Medicine Products: